These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30038895)

  • 1. Gram scale preparation of clozapine
    van der Peet PL; Gunawan C; Abdul-Ridha A; Ma S; Scott DJ; Gundlach AL; Bathgate RAD; White JM; Williams SJ
    MethodsX; 2018; 5():257-267. PubMed ID: 30038895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The first structure-activity relationship studies for designer receptors exclusively activated by designer drugs.
    Chen X; Choo H; Huang XP; Yang X; Stone O; Roth BL; Jin J
    ACS Chem Neurosci; 2015 Mar; 6(3):476-84. PubMed ID: 25587888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of clozapine-N-oxide and compound 21 on sleep in laboratory mice.
    Traut J; Mengual JP; Meijer EJ; McKillop LE; Alfonsa H; Hoerder-Suabedissen A; Song SH; Fehér KD; Riemann D; Molnar Z; Akerman CJ; Vyazovskiy VV; Krone LB
    Elife; 2023 Mar; 12():. PubMed ID: 36892930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DREADD Agonist 21 Is an Effective Agonist for Muscarinic-Based DREADDs
    Thompson KJ; Khajehali E; Bradley SJ; Navarrete JS; Huang XP; Slocum S; Jin J; Liu J; Xiong Y; Olsen RHJ; Diberto JF; Boyt KM; Pina MM; Pati D; Molloy C; Bundgaard C; Sexton PM; Kash TL; Krashes MJ; Christopoulos A; Roth BL; Tobin AB
    ACS Pharmacol Transl Sci; 2018 Sep; 1(1):61-72. PubMed ID: 30868140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemogenetics revealed: DREADD occupancy and activation via converted clozapine.
    Gomez JL; Bonaventura J; Lesniak W; Mathews WB; Sysa-Shah P; Rodriguez LA; Ellis RJ; Richie CT; Harvey BK; Dannals RF; Pomper MG; Bonci A; Michaelides M
    Science; 2017 Aug; 357(6350):503-507. PubMed ID: 28774929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism and Distribution of Clozapine-N-oxide: Implications for Nonhuman Primate Chemogenetics.
    Raper J; Morrison RD; Daniels JS; Howell L; Bachevalier J; Wichmann T; Galvan A
    ACS Chem Neurosci; 2017 Jul; 8(7):1570-1576. PubMed ID: 28324647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine N-Oxide Administration Produces Behavioral Effects in Long-Evans Rats: Implications for Designing DREADD Experiments.
    MacLaren DA; Browne RW; Shaw JK; Krishnan Radhakrishnan S; Khare P; España RA; Clark SD
    eNeuro; 2016; 3(5):. PubMed ID: 27822508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral Effect of Chemogenetic Inhibition Is Directly Related to Receptor Transduction Levels in Rhesus Monkeys.
    Upright NA; Brookshire SW; Schnebelen W; Damatac CG; Hof PR; Browning PGF; Croxson PL; Rudebeck PH; Baxter MG
    J Neurosci; 2018 Sep; 38(37):7969-7975. PubMed ID: 30082415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does chronic systemic injection of the DREADD agonists clozapine-N-oxide or Compound 21 change behavior relevant to locomotion, exploration, anxiety, and depression in male non-DREADD-expressing mice?
    Tran FH; Spears SL; Ahn KJ; Eisch AJ; Yun S
    Neurosci Lett; 2020 Nov; 739():135432. PubMed ID: 33080350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DREADD-based synthetic control of chondrocyte calcium signaling in vitro.
    McDonough RC; Shoga JS; Price C
    J Orthop Res; 2019 Jul; 37(7):1518-1529. PubMed ID: 30908734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent reduction in cocaine-induced locomotion by Clozapine-N-Oxide in rats with a history of cocaine self-administration.
    Padovan-Hernandez Y; Knackstedt LA
    Neurosci Lett; 2018 May; 674():132-135. PubMed ID: 29571824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G
    Marciante AB; Farmer GE; Cunningham JT
    J Neurophysiol; 2020 Aug; 124(2):591-609. PubMed ID: 32697679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and pharmacodynamic actions of clozapine-N-oxide, clozapine, and compound 21 in DREADD-based chemogenetics in mice.
    Jendryka M; Palchaudhuri M; Ursu D; van der Veen B; Liss B; Kätzel D; Nissen W; Pekcec A
    Sci Rep; 2019 Mar; 9(1):4522. PubMed ID: 30872749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemogenetic Activation of Excitatory Neurons Alters Hippocampal Neurotransmission in a Dose-Dependent Manner.
    Pati S; Salvi SS; Kallianpur M; Vaidya B; Banerjee A; Maiti S; Clement JP; Vaidya VA
    eNeuro; 2019; 6(6):. PubMed ID: 31645362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice.
    Manvich DF; Webster KA; Foster SL; Farrell MS; Ritchie JC; Porter JH; Weinshenker D
    Sci Rep; 2018 Mar; 8(1):3840. PubMed ID: 29497149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated chemogenetic activation of dopaminergic neurons induces reversible changes in baseline and amphetamine-induced behaviors.
    Chohan MO; Fein H; Mirro S; O'Reilly KC; Veenstra-VanderWeele J
    Psychopharmacology (Berl); 2023 Dec; 240(12):2545-2560. PubMed ID: 37594501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and functional characterization of a novel, arrestin-biased designer G protein-coupled receptor.
    Nakajima K; Wess J
    Mol Pharmacol; 2012 Oct; 82(4):575-82. PubMed ID: 22821234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic hM3Dq signaling in microglia ameliorates neuroinflammation in male mice.
    Binning W; Hogan-Cann AE; Yae Sakae D; Maksoud M; Ostapchenko V; Al-Onaizi M; Matovic S; Lu WY; Prado MAM; Inoue W; Prado VF
    Brain Behav Immun; 2020 Aug; 88():791-801. PubMed ID: 32434046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric modulation of a chemogenetically modified G protein-coupled receptor.
    Abdul-Ridha A; Lane JR; Sexton PM; Canals M; Christopoulos A
    Mol Pharmacol; 2013 Feb; 83(2):521-30. PubMed ID: 23197649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral application of clozapine-N-oxide using the micropipette-guided drug administration (MDA) method in mouse DREADD systems.
    Schalbetter SM; Mueller FS; Scarborough J; Richetto J; Weber-Stadlbauer U; Meyer U; Notter T
    Lab Anim (NY); 2021 Mar; 50(3):69-75. PubMed ID: 33619409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.